Skip to main content
Figure 7 | BMC Complementary and Alternative Medicine

Figure 7

From: Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain

Figure 7

Effects of CTS and THA on VEGF/VEGFR2 and PDGF/PDGFR expression in the hippocampus of db/db mouse. A) Typical photos indicating the expression levels of each factor in the hippocampus of vehicle-treated m/m (lane a), and vehicle (lane b)-, CTS (325 mg/kg per day: lane c; 750 mg/kg per day: lane d)-, and THA (2.5 mg/kg per day; lane e)-treated db/db mice. B) Quantitative comparisons of each factor among different animal groups were conducted as described in the text. The data are expressed as the percentage of the value obtained from naïve control m/m mice. Each data column represents the mean ± S.D. obtained from 5 – 6 brain samples. #P < 0.05, ##P < 0.01 vs. vehicle-treated m/m group (Student’s t-test). *P < 0.05, **P < 0.01, ***P < 0.001 vs. respective vehicle-treated db/db group (one-way ANOVA followed by Tukey test).

Back to article page